Senseonics (NYSE:SENS) announced today that it integrated SweetSpot software with its Eversense 365 continuous glucose monitor (CGM) in the U.S. The software integration provides endocrinology practices that partner with SweetSpot the ability to seamlessly and regularly review data from patients using Eversense 365, the world’s first and only one-year CGM. Senseonics won FDA clearance for the Eversense […]
